Detailed information
Barkacine is Bromhexine - HCL -2 Amino- 3.5 Dibromoben- Zyl (cyclohexyl) Methylammonium HCL.
COMPOSITION:
Each tablet contains : 8mg Bromhexine HC1.
Each 1 ml Oral drops contains : 2mg Bromhexine HC1.
Each 5ml syrup contains : 4mg Bromhexine HC1.
PROPERTIES:
Barkacine is a mucolytic agent and expectorant which changes the structure of bronchial sectretion by rarefication and fragmentation of the mucopolysacharide fibers leading to a reduction in the viscosity of the sputum.
INDICATIONS:
Barkacine is used in the treatment of conditions in the respiratory tract associated with retention ofmucoid sectretion. ie. bronchitis and asthma
PRECAUTIONS:
It is advised not to administer Barkacine with atropine based preparations It should be used with caution to patients with gastric ulceration.
SIDE EFFECTS:
Very rare cases ofgastro - intestinal disturbances and increased serum transaminase level have been reported .
CONTRAINDICATIONS: None.
DOSAGES:
Children above 12 and adults. 8 to 16 mg. 3-4 times daily Children 5-12 years : 4 mg. 3-4 times daily Children 1 - 5 years: 4 mg. twice daily
PRESENTATIONS:
Boxes of 20 tablets Bottle of 30ml drops Bottle of 100ml syrup |
